Difference between revisions of "CLMAT3"

From LncRNAWiki
Jump to: navigation, search
(Created page with "==Annotated Information== ===Approved Symbol=== CLMAT3 ===Approved Name=== colorectal liver metastasis associated transcript 3 ===Previous Symbols=== _ ===Synonyms=== SPARC-AS...")
 
 
(6 intermediate revisions by 2 users not shown)
Line 4: Line 4:
 
===Approved Name===
 
===Approved Name===
 
colorectal liver metastasis associated transcript 3
 
colorectal liver metastasis associated transcript 3
===Previous Symbols===
+
[[File:The CLMAT3 expression levels in 90 paired CRC and normal tissue samples were analyzed via a qRT-PCR assay.png|right|thumb|400px|'''The CLMAT3 expression levels in 90 paired CRC and normal tissue samples were analyzed via a qRT-PCR assay'''<ref name="ref1" />]]
_
 
 
===Synonyms===
 
===Synonyms===
 
SPARC-AS1
 
SPARC-AS1
===Chromosome===
 
5q33.1
 
===RefSeq ID===
 
NR_109873
 
===OMIM ID===
 
_
 
 
===RefSeq(supplied by NCBI)===
 
===RefSeq(supplied by NCBI)===
 
NR_109873
 
NR_109873
===pubmed IDs===
+
===Characteristics===
26050227
+
CLMAT3 is located on human chromosome 14 (chr14:101379770-101381326, hg19) <ref name="ref1" />.
 +
 
 +
===Expression===
 +
CLMAT3 is significantly up-regulated in the cancerous tissues comparing with the normal colorectal tissues, and high CLMAT3 expression strongly correlates with liver metastasis and lymph node metastasis, and shorter median overall survival duration <ref name="ref1" />.
 +
 
 +
===Function===
 +
CLMAT3 over-expression is significantly associated with colorectal liver metastasis and is an independent predictor of poor survival for patients with colorectal cancer, indicating that CLMAT3 may act as an oncogene <ref name="ref1" />.
 +
===Disease===
 +
* colorectal cancer <ref name="ref1" />
 +
 
 +
==Labs working on this lncRNA==
 +
* Department of Oncological Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, People's Republic of China.<ref name="ref1" />
 +
* Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200000, People's Republic of China.<ref name="ref1" />
 +
 
 +
==References==
 +
<references>
 +
<ref name="ref1"> Ye, L.C., et al., Aberrant expression of long noncoding RNAs in colorectal cancer with liver metastasis. Tumour Biol, 2015. 36(11): p. 8747-54.
 +
</ref>(1)
 +
</references>

Latest revision as of 09:58, 7 December 2017

Annotated Information

Approved Symbol

CLMAT3

Approved Name

colorectal liver metastasis associated transcript 3

The CLMAT3 expression levels in 90 paired CRC and normal tissue samples were analyzed via a qRT-PCR assay[1]

Synonyms

SPARC-AS1

RefSeq(supplied by NCBI)

NR_109873

Characteristics

CLMAT3 is located on human chromosome 14 (chr14:101379770-101381326, hg19) [1].

Expression

CLMAT3 is significantly up-regulated in the cancerous tissues comparing with the normal colorectal tissues, and high CLMAT3 expression strongly correlates with liver metastasis and lymph node metastasis, and shorter median overall survival duration [1].

Function

CLMAT3 over-expression is significantly associated with colorectal liver metastasis and is an independent predictor of poor survival for patients with colorectal cancer, indicating that CLMAT3 may act as an oncogene [1].

Disease

  • colorectal cancer [1]

Labs working on this lncRNA

  • Department of Oncological Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, People's Republic of China.[1]
  • Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200000, People's Republic of China.[1]

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 Ye, L.C., et al., Aberrant expression of long noncoding RNAs in colorectal cancer with liver metastasis. Tumour Biol, 2015. 36(11): p. 8747-54.